000			04108nam a2200433 i 4500
999			_c362898 _d362898 _x1
001			362898
003			ES-MaUEC
005			20230102121631.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			210813s2021 sz | o |||| 0|eng d
020			_a9783030745219
024	7		_a10.1007/978-3-030-74521-9 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRA425 _b2021 EB
100	1		_aLazris, Andy _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _9682441
245	1	0	_aUtilizing Effective Risk Communication in COVID-19 : _bHighlighting the BRCT _cby Andy Lazris, Erik Rifkin
250			_aFirst edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
300			_a1 recurso en línea (XV, 131 páginas) _b18 ilustraciones, 17 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
505	0		_aPART I: Communicating Risk and Benefit in the Medical Community -- Patients, Doctors and Decision-making -- Absolute and Relative Risks -- Communicating health risks to patients and the public -- Erik's Recent Experience with Doctors and a Heart Attack -- Why not all numbers are the same -- Putting BRCTs to use in helping people understand health outcomes -- PART II: Videos to Describe the Utility of BRCTs -- PART III: COVID-19 Communication -- Segue to Part III: BRCTs & COVID-19 -- How important are the number of cases? -- The demographics of COVID-19 -- Why COVID-19 Should Not Have Prevented Colleges (and Elementary and Secondary Schools) from Opening Last Fall -- Nursing homes, the nidus of COVID-19 death -- The use of universal masking -- Communicating about the impact of surges and quarantines -- Communicating about the adverse effects of the cure -- How we communicate about COVID-19 in other countries -- Other viral pandemics with reference to COVID-19 -- A Path Forward: BRCTs for COVID-19 and Beyond.
520			_aThis book demonstrates how a novel decision-aid, called a Benefit-Risk Characterization Theater (BRCT), can be used to: · Significantly improve accurate communication of health risks from exposure to COVID-19; and · Assess how to best contain and control COVID-19. To date, there have been far-reaching ramifications based on ineffective risk communication when clarifying these health endpoints. A BRCT is a familiar, theatrical chart representation of 1,000 people, with the risks and benefits shown by blackened seats. Since health outcomes can easily be put into such a chart, we show how BRCTs can be used objectively by professionals, the media and lay people. It allows characterization and communication of health benefits and risks of COVID-19 treatment and containment in an undemanding and straightforward way. BRCTs have been successfully used to assist patients in determining: · Their level of acceptable risk of various medical interventions; · If the benefits of intervention outweigh the risks; · Who should make the final decision regarding medical intervention; and · Whether the decision is evidence-based. Written by experts in the field, this book fills in a gap in communication between the medical community, the public and patients. It also provides an area of expertise in communication that is beneficial for medical providers and medical students.
988			_aSpringer_Medicine_2021
650		7	_2embne _9138408 _aSalud pública
650		7	_2embne _aCOVID-19 _9683668
700			_aRifkin, Erik _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _995018
776	0	8	_iPrinted edition: _z9783030745202
776	0	8	_iPrinted edition: _z9783030745226
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-74521-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2022 _dz _eb _zSI